Blackfynn
New tools and technologies are generating vast quantities of highly complex and diverse data. Electrical recordings, radiology imaging, genomics, pathology, neurochemistry, device and patient clinical data — together — could hold the keys to understanding the basis of human disease. Breakthrough discoveries that could lead to novel therapeutics have been hindered by an inability to see, use, collaborate around, analyze and interrogate all data types in combination to find new data patterns.
We built our platform to solve this problem. We came together to improve the lives of the more than one billion people worldwide who are living with Epilepsy, Alzheimer’s disease, Parkinson’s disease, ALS and other neurological diseases.
